Jun 30, 2023

Entrada Therapeutics Q2 2023 Earnings Report

Total Revenue
$18.2M
EPS
-$0.78
Previous year: -$0.74
+5.4%
Gross Profit
$17.5M
Cash and Equivalents
$79.7M
Previous year: $90.9M
-12.2%
Free Cash Flow
-$36.6M
Previous year: -$18.8M
+94.9%
Total Assets
$494M
Previous year: $296M
+66.9%

Entrada Therapeutics

Entrada Therapeutics